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Table 1. — Butyrate oxidation and TST activity in UC compared to control colon (mean ± st dev)
Significantly different from control colon (a) and quiescent UC (b) : p < 0.01.
Conclusions : Our study suggest that impaired butyrate oxidation is closely linked to the sulphide detoxification
capacity of the mucosa in ulcerative colitis. The sulphide detoxification mechanism could explain the well-document-
ed observation that cigarette smoking is beneficial in ulcerative colitis. Smoking increases blood cyanide levels and the
colon has been shown to extract cyanide from blood. Hence, this cyanide could enhance the removal of thiosulphate
from the colonic mucosa and thus facilitate the metabolism of sulphide to thiosulphate.
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RIENCE 2002-2007. O. Detry (1), V. Donckier (2), V. Lucidi (2), D. Ysebaert (3), T. Chapelle (3), J. Lerut (4),
O. Ciccarelli (4), J. Pirenne (5), D. Monbaliu (5), A. Deroover (1), P. Honoré (1), X. Rogiers (6), B. de Hemptinne (6),
R. Troisi (6). (1) ULg, (2) ULB Erasme, (3) UZ Antwerpen, (4) UCL Saint-Luc, (5) KULeuven Gasthuisberg, (6) UZ Gent.
Introduction : DCD organ donors were recently proposed as a potential source of transplantable organs. All Belgian
transplant centres developed an active program of DCD liver transplantation and participated to this study. We retro-
spectively reviewed the global Belgian experience in order to evaluate this experience and to analyse the posttransplant
results in terms of patient and graft survivals, and in biliary complications. 
Patients and methods : From 2003 to 2007, 58 DCD liver transplantations were performed in Belgium, 52 from
Maastricht category III, 2 from category IV donors, and 4 after euthanasia. Amongst these 58 transplantations, 39 were
performed with graft procured locally, and 14 from another Belgian centre and 5 from The Netherlands). Mean donor
age was 44 years (range, 17-71). 32.7% were female. Mean donor BMI was 24.5. Mean ICU stay was 4.8 days (range,
0-19). Mean donor sodium level was 142.3 ± 0.8 mmol/L (mean ± SEM). Mean donor AST and GGT was 50.5 ±
5.7 U/L and 59.8 ± 12.1 U/L, respectively. Causes of brain lesions were trauma (23 cases), intracranial bleeding
(17 cases) and ischemic (14 cases). All life support withdrawals were performed in the operating theatre. Mean delay
between respiratory withdrawal and cardiac arrest was 14.7 min. Mean delay between respiratory withdrawal and  aortic
flush was 25 min. HTK was the most used preservation solution. Mean age of recipients was 55 years (range, 10-70).
Mean MELD score at transplant was 15.8. Indication of liver transplantation was decompensated cirrhosis and/or
hepato carcinoma in most cases. 
Results : Mean cold ischemia was 451 min (range, 148-770). Peak of transminases was 2,241 ± 338 UI/mL. Global
patient survival was 91.3%, 81.2% and 68.1% at 1 month, 1 year and 2 years, respectively. Graft survival was 84.4%,
70.3% and 49.7% at 1 month, 1 year and 2 years, respectively. Causes of early mortality (n = 5) were operative death
(n = 2), PNF, MOF and ARDS. Late deaths (n = 8) were due to accident (n = 2), malignant tumour (n = 5) and biliary
sepsis. Two patients needed early retransplantation for PNF and hepatic artery thrombosis. Six patients needed later
retransplantation for diffuse bile duct lesions. Eleven other patients developed biliary stenoses requiring endoscopy
and/or surgery. In univariate analysis, significant donor factors for death were delay between respiratory arrest and
 cardiac arrest of more than 15 min, and cold ischemia of more than 6 hours. In the recipient factors, HU status of the
recipient was the only significant risk factor for early death. Donor BMI > 25 was related to an icreased peak bilirubin. 
Conclusion : DCD organ donors may be a source of viable liver grafts. However actual results are inferior to the results
of liver transplantation from donors after brain death, and prognostic criteria should be evaluated to improve the results.
Further experience is needed to determine these risk factors.
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Butyrate oxidation TST activity
Controls (n = 17) 23.0 ± 13.8 81.6 ± 24.1
UC (n = 33) 5.6 ± 5.2 a 32.5 ± 21.5 a
Mayo 0-1 (n = 12) 10.2 ± 5.3 a 50.8 ± 19.1 a
Mayo 2 (n = 5) 2.0 ± 1.4 a,b 26.3 ± 10.6 a,b
Mayo 3 (n = 13) 2.7 ± 1.2 a,b 18.1 ± 13.1 a,b
